中国全科医学
中國全科醫學
중국전과의학
Chinese General Practice
2015年
26期
3185-3187,3188
,共4页
邢东亮%宋东奎%康郑军%酒涛
邢東亮%宋東奎%康鄭軍%酒濤
형동량%송동규%강정군%주도
膀胱肿瘤%Krüppel样因子%高迁移率族蛋白质类%预后
膀胱腫瘤%Krüppel樣因子%高遷移率族蛋白質類%預後
방광종류%Krüppel양인자%고천이솔족단백질류%예후
Urinary bladder neoplasms%Krüppel-like factor%High mobility group proteins%Prognosis
目的:探讨膀胱尿路上皮癌组织Krüppel样因子8( KLF8)以及高迁移率族蛋白A2( HmGA2)表达水平及其与预后的相关性。方法选取2012年1月—2013年10月在郑州大学第五附属医院就诊的74例膀胱尿路上皮癌患者的肿瘤组织作为研究组,另选取同期在本院行膀胱切开取石术或开放前列腺切除术患者23例的膀胱黏膜作为对照组。采用免疫组化方法检测两组标本组织中KLF8和HmGA2蛋白表达水平。采用Cox回归分析KLF8及HmGA2蛋白的表达水平与患者生存预后的关系。结果研究组KLF8和HmGA2表达水平均高于对照组,差异有统计学意义( t=3.872,P=0.002;t=4.593,P=0.001)。膀胱尿路上皮癌患者临床分期与KLF8和HmGA2表达水平均呈正相关,差异有统计学意义(rs =0.489、0.561,P<0.05)。患者均随访至2015年4月,67例患者在随访截止时存活,总生存率为90.5%。多元Cox回归分析结果显示,临床病理分期、KLF8和HmGA2表达水平是膀胱尿路上皮癌患者生存预后的影响因素(P<0.05)。结论膀胱尿路上皮癌组织KLF8及HmGA2蛋白的高水平表达是患者生存预后的危险因素。
目的:探討膀胱尿路上皮癌組織Krüppel樣因子8( KLF8)以及高遷移率族蛋白A2( HmGA2)錶達水平及其與預後的相關性。方法選取2012年1月—2013年10月在鄭州大學第五附屬醫院就診的74例膀胱尿路上皮癌患者的腫瘤組織作為研究組,另選取同期在本院行膀胱切開取石術或開放前列腺切除術患者23例的膀胱黏膜作為對照組。採用免疫組化方法檢測兩組標本組織中KLF8和HmGA2蛋白錶達水平。採用Cox迴歸分析KLF8及HmGA2蛋白的錶達水平與患者生存預後的關繫。結果研究組KLF8和HmGA2錶達水平均高于對照組,差異有統計學意義( t=3.872,P=0.002;t=4.593,P=0.001)。膀胱尿路上皮癌患者臨床分期與KLF8和HmGA2錶達水平均呈正相關,差異有統計學意義(rs =0.489、0.561,P<0.05)。患者均隨訪至2015年4月,67例患者在隨訪截止時存活,總生存率為90.5%。多元Cox迴歸分析結果顯示,臨床病理分期、KLF8和HmGA2錶達水平是膀胱尿路上皮癌患者生存預後的影響因素(P<0.05)。結論膀胱尿路上皮癌組織KLF8及HmGA2蛋白的高水平錶達是患者生存預後的危險因素。
목적:탐토방광뇨로상피암조직Krüppel양인자8( KLF8)이급고천이솔족단백A2( HmGA2)표체수평급기여예후적상관성。방법선취2012년1월—2013년10월재정주대학제오부속의원취진적74례방광뇨로상피암환자적종류조직작위연구조,령선취동기재본원행방광절개취석술혹개방전렬선절제술환자23례적방광점막작위대조조。채용면역조화방법검측량조표본조직중KLF8화HmGA2단백표체수평。채용Cox회귀분석KLF8급HmGA2단백적표체수평여환자생존예후적관계。결과연구조KLF8화HmGA2표체수평균고우대조조,차이유통계학의의( t=3.872,P=0.002;t=4.593,P=0.001)。방광뇨로상피암환자림상분기여KLF8화HmGA2표체수평균정정상관,차이유통계학의의(rs =0.489、0.561,P<0.05)。환자균수방지2015년4월,67례환자재수방절지시존활,총생존솔위90.5%。다원Cox회귀분석결과현시,림상병리분기、KLF8화HmGA2표체수평시방광뇨로상피암환자생존예후적영향인소(P<0.05)。결론방광뇨로상피암조직KLF8급HmGA2단백적고수평표체시환자생존예후적위험인소。
Objective To investigate the correlation between the expression levels of KLF8 and HmGA2 protein and the prognosis of patients with bladder urothelial carcinoma. Methods We obtained tissues of carcinoma niduses from 74 patients with bladder urothelial carcinoma who received treatment in the Fifth Affiliated Hospital of Zhengzhou University from January 2012 to October 2013 as research group,and we collected the bladder mucous membranes from 23 patients who underwent cystolithotomy or open prostatectomy in the same hospital in the same period as the control group. Immunohistochemical method was employed to examine the expression levels of KLF8 and HmGA2 protein of the two groups. Cox regression analysis was undertaken to investigate the relation between the expression levels of KLF8 and HmGA2 protein and survival prognosis. Results Research group was higher than control group in the expression level of KLF8 and HmGA2(t =3. 872,P =0. 002;t =4. 593,P=0. 001). There was positive correlation between clinical staging of patients with bladder urothelial carcinoma and the expression levels of KLF8 and HmGA2(rs =0. 489,0. 561;P<0. 05). The follow-up visits were finished in April 2015, where the number of surviving patients was 67 with a total survival rate of 90. 5%. The Cox multivariate regression analysis showed that clinical pathological staging and the expression levels of KLF8 and HmGA2 were influencing factors for the survival prognosis of patients with bladder urothelial carcinoma ( P <0. 05 ). Conclusion The high expression levels of KLF8 and HmGA2 protein are risk factors for the survival prognosis of patients with bladder urothelial carcinoma.